6-Bromo-1-methyl-1,2,3,4-tetrahydroquinoxaline, 95.0%, 1g

N,N'-Bis[4-chloro-3-(trifluoromethyl)phenyl]urea, 98%, 250mg

1-(2-Chlorophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid, 97%, 1g

Chlorure de thionyle, min.98%, pour la synthèse, 500 ml, emballage en verre

4-Fluorobenzaldehyde, 96.00%, 10g

(2S)-2-[[[[3,5-Bis(trifluoromethyl)phenyl]amino]thioxomethyl]amino]-N-(diphenylmethyl)-N,3,3-trimethylbutanamide, 97%, 250mg

2-Cyano-benzo[d]oxazole, 97.0%, 1g

(trans,trans)-4'-Propyl-[1,1'-bi(cyclohexan)]-4-ol, 95.0%, 25g

(4-Nitro-pyrazol-1-yl)-acetic acid, 95.0%, 1g

1-(tert-Butylamino)-3-chloropropan-2-ol hydrochloride, 95.0%, 1g

5-OXA-7-AZASPIRO[3.4]OCTAN-6-ONE, 95.0%, 250mg

Bloc d'échange d'accessoires pour récipients de réaction, Gesch. pour, 24 récipients de réaction 0,5 ml, 1 pièce

(3S,4S)-4-(4-Bromophenoxy)tetrahydrofuran-3-amine, 97%, 1g